Page 1 | Search Results | Blood | American Society of Hematology

1-13 of 13

Sort by

Sort Order Select

Journal Articles

Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia

Blood (2009) 113 (3): 626–634.

https://doi.org/10.1182/blood-2007-10-116848

Published: 2009

Journal Articles

CD27-CD70 interactions in the pathogenesis of Waldenström macroglobulinemia

Allen W. Ho, Evdoxia Hatjiharissi, Bryan T. Ciccarelli, Andrew R. Branagan, Zachary R. Hunter, Xavier Leleu, Olivier Tournilhac, Lian Xu, Kelly O'Connor, Robert J. Manning, Daniel Ditzel Santos, Mariana Chemaly, Christopher J. Patterson, Jacob D. Soumerai, Nikhil C. Munshi, Julie A. McEarchern, Che-Leung Law, Iqbal S. Grewal, Steven P. Treon

Blood (2008) 112 (12): 4683–4689.

https://doi.org/10.1182/blood-2007-04-084525

Published: 2008

Journal Articles

Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level

Reinhard E. Marks, Allen W. Ho, Christian Robbel, Todd Kuna, Seth Berk, Thomas F. Gajewski

Blood (2007) 110 (6): 1982–1988.

https://doi.org/10.1182/blood-2006-06-031088

Published: 2007

Journal Articles

Abnormal Expression of TRAF Adapter Proteins in Waldenstrom’s Macroglobulinemia.

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Anne-Sophie Moreau, MD, Xiaoying Jia, Garrett O’Sullivan, Vinod Bakthavachalam, Allen W. Ho, Evdoxia Hatjiharissi, MD, Hai T. N’Go, Daniel D. Santos, MD, Kelly O’Connor, Robert Manning, Jacob Soumerai, Christopher Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2006) 108 (11): 4640.

https://doi.org/10.1182/blood.V108.11.4640.4640

Published: 2006

Journal Articles

Endoplasmic Reticulum Stress Is a Target for Therapy in Waldenstrom’s Macroglobulinemia (WM).

Xavier Leleu, MD, Lian Xu, Zachary R. Hunter, Xiaoying Jia, Anne-Sophie Moreau, MD, Allen W. Ho, Evdoxia Hatjiharissi, MD, Hai N’Go, Daniel D. Santos, MD, Kelly O’Connor, Robert Manning, Jacob Soumerai, Christopher Patterson, Irene M. Ghobrial, MD, Steven P. Treon, MD

Blood (2006) 108 (11): 4641.

https://doi.org/10.1182/blood.V108.11.4641.4641

Published: 2006

Journal Articles

Preclinical In Vitro and In Vivo Evidence Support a Therapeutic Role for the CD70 Directed Monoclonal Antibody (SGN-70) in Waldenström’s Macroglobulinemia (WM).

Evdoxia Hatjiharissi, MD, Allen W. Ho, Lian Xu, Kelly E. O’Connor, Zachary R. Hunter, Daniel D. Santos, MD, Robert Manning, Xavier Leleu, MD, Anne-Sophie Moreau, MD, Christopher J. Patterson, Julie A. McEarchern, PhD, Che-Leung Law, PhD, Iqbal S. Grewal, PhD, Nikhil C. Munshi, MD, PhD, Steven P. Treon, MD, PhD

Blood (2006) 108 (11): 2490.

https://doi.org/10.1182/blood.V108.11.2490.2490

Published: 2006

Journal Articles

A Novel Functional Role for Soluble CD27 in the Pathogenesis of Waldenstrom’s Macroglobulinemia.

Allen W. Ho, Xavier Leleu, MD, Evdoxia Hatjiharissi, MD, Olivier Tournilhac, MD, Lian Xu, Kelly O’Connor, Robert Manning, Daniel Santos, MD, Mariana Chemaly, MD, Andrew Branagan, Zachary Hunter, Christopher Patterson, Kenneth C. Anderson, MD, Steven P. Treon, MD, PhD

Blood (2005) 106 (11): 4701.

https://doi.org/10.1182/blood.V106.11.4701.4701

Published: 2005

Journal Articles

Individuals Expressing FcγRIIIA-158 V/V and V/F Show Increased NK Cell Surface Expression of FcgRIIIA (CD16), Rituximab Binding, and Demonstrate Higher Levels of ADCC Activity in Response to Rituximab.

Evdoxia Hatjiharissi, MD, Daniel Ditzel Santos, MD, Lian Xu, Sigitas Verselis, PhD, Michael Modica, PhD, Xavier Leleu, MD, Zachary Hunter, Allen W. Ho, Robert Manning, Christopher Patterson, Kenneth C. Anderson, MD, Edward Fox, PhD, Steven P. Treon, MD, PhD

Blood (2005) 106 (11): 776.

https://doi.org/10.1182/blood.V106.11.776.776

Published: 2005

Journal Articles

Establishment of a Waldenstrom’s Macroglobulinemia Cell Line (BCWM.1) with Productive In Vivo Engraftment in SCID-hu Mice.

Blood (2005) 106 (11): 979.

https://doi.org/10.1182/blood.V106.11.979.979

Published: 2005

Journal Articles

Bone Marrow Mast Cells Are Significantly Increased in Patients with Waldenstrom’s Macroglobulinemia, and Their Number Following Therapeutic Intervention Is Dependent on Extent of Response.

Daniel Ditzel Santos, MD, Mariana Z.A. Chemaly, MD, Olivier Tournilhac, MD, Kelly E. OConnor, Evdoxia Hatjiharissi, MD, Xavier Leleu, MD, Lian Xu, Andrew R. Branagan, Robert J. Manning, Christopher Patterson, Allen W. Ho, Zachary R. Hunter, James M. You, MD. Phd, Yu-Tzu Tai, Phd, Jeffery L. Kutok, Kenneth C. Anderson, Nikhil Munshi, Steven P. Treon

Blood (2005) 106 (11): 980.

https://doi.org/10.1182/blood.V106.11.980.980

Published: 2005

Journal Articles

Polymorphisms in Fc γ RIIIA Are Genetically Linked to FcγRIIA and May Account for the Primary Predictive Role Ascribed to Polymorphisms in FcγRIIIA-158 in Determining Rituximab Responses.

Evdoxia Hatjiharissi, MD, Mark Hansen, Sigitas Verselis, PhD, Daniel Ditzel Santos, MD, Lian Xu, Robert Manning, Zachary Hunter, Xavier Leleu, MD, Allen W. Ho, Christopher J. Patterson, Edward Fox, PhD, Steven P. Treon, MD, PhD

Blood (2005) 106 (11): 2433.

https://doi.org/10.1182/blood.V106.11.2433.2433

Published: 2005

Journal Articles

The Unfolded Protein Response Is a Determinant of Disease Actvity in Waldenstrom’s Macroglobulinemia (WM).

Xavier Leleu, MD, Lian Xu, Daniel D. Santos, MD, Allen W. Ho, Zachary R. Hunter, Kelly O’Connor, Robert J. Manning, Olivier Tournilhac, MD, Mariana Chemaly, Andrew R. Branagan, Christopher J. Patterson, Kenneth C. Anderson, MD, Steven Treon, MD

Blood (2005) 106 (11): 996.

https://doi.org/10.1182/blood.V106.11.996.996

Published: 2005

Journal Articles

Abnormal Expression of the Plasma Cell Differentiation Factor X-Box Protein 1 (Xbp-1) in Waldenstrom’s Macroglobulinemia.

Lian Xu, Xavier Leleu, MD, Zachary R. Hunter, Daniel D. Santos, MD, Allen W. Ho, Evdoxia Hatjiharissi, MD, Kelly O’Connor, Robert J. Manning, Mariana Chemaly, Andrew R. Branagan, Christopher J. Patterson, Sigitas Verselis, Edward Fox, Kenneth C. Anderson, MD, Steven Treon, MD

Blood (2005) 106 (11): 1003.

https://doi.org/10.1182/blood.V106.11.1003.1003

Published: 2005

NARROW

Endoplasmic reticulum stress is a target for therapy in Waldenstrom macroglobulinemia

CD27-CD70 interactions in the pathogenesis of Waldenström macroglobulinemia

Farnesyltransferase inhibitors inhibit T-cell cytokine production at the posttranscriptional level

Abnormal Expression of TRAF Adapter Proteins in Waldenstrom’s Macroglobulinemia.

Endoplasmic Reticulum Stress Is a Target for Therapy in Waldenstrom’s Macroglobulinemia (WM).

Preclinical In Vitro and In Vivo Evidence Support a Therapeutic Role for the CD70 Directed Monoclonal Antibody (SGN-70) in Waldenström’s Macroglobulinemia (WM).

A Novel Functional Role for Soluble CD27 in the Pathogenesis of Waldenstrom’s Macroglobulinemia.

Individuals Expressing FcγRIIIA-158 V/V and V/F Show Increased NK Cell Surface Expression of FcgRIIIA (CD16), Rituximab Binding, and Demonstrate Higher Levels of ADCC Activity in Response to Rituximab.

Establishment of a Waldenstrom’s Macroglobulinemia Cell Line (BCWM.1) with Productive In Vivo Engraftment in SCID-hu Mice.

Bone Marrow Mast Cells Are Significantly Increased in Patients with Waldenstrom’s Macroglobulinemia, and Their Number Following Therapeutic Intervention Is Dependent on Extent of Response.

Polymorphisms in Fc γ RIIIA Are Genetically Linked to FcγRIIA and May Account for the Primary Predictive Role Ascribed to Polymorphisms in FcγRIIIA-158 in Determining Rituximab Responses.

The Unfolded Protein Response Is a Determinant of Disease Actvity in Waldenstrom’s Macroglobulinemia (WM).

Abnormal Expression of the Plasma Cell Differentiation Factor X-Box Protein 1 (Xbp-1) in Waldenstrom’s Macroglobulinemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only